Metabolomic changes in the rat retina after optic nerve crush

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 6, 2013, Pages 4249-4259

  Agudo Barriuso, Marta ^a,b   Lahoz, Agustín ^c   Nadal Nicolás, Francisco M ^a,b   Sobrado Calvo, Paloma ^a   Piquer Gil, Marina ^c   Díaz Llopis, Manuel ^d   Vidal Sanz, Manuel ^b   Mullor, José L ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Amino acid metabolism; Axotomy; Carbohydrate; Central nervous system; Ceramide; Glutathione; Multivariate data analysis; Oxidative stress; Translation; Trauma

Indexed keywords

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; LIPID METABOLISM; METABOLITE; METABOLOMICS; NONHUMAN; OPTIC NERVE INJURY; OXIDATIVE STRESS; PRIORITY JOURNAL; PURINE METABOLISM; RAT; RNA TRANSLATION; VITAMIN METABOLISM; XENOBIOTIC METABOLISM;

AMINO ACID METABOLISM; AXOTOMY; CARBOHYDRATE; CENTRAL NERVOUS SYSTEM; CERAMIDE; GLUTATHIONE; MULTIVARIATE DATA ANALYSIS; OXIDATIVE STRESS; TRANSLATION; TRAUMA;

AMINO ACIDS; ANIMALS; APOPTOSIS; AXONS; AXOTOMY; CARBOHYDRATE METABOLISM; CHROMATOGRAPHY, LIQUID; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LIPID METABOLISM; METABOLOMICS; NERVE CRUSH; OPTIC NERVE; OXIDATIVE STRESS; PROTEIN ARRAY ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 84879138294     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11451     Document Type: Article

References (62)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82:844-851.
2. Agudo-Barriuso M, Villegas-Perez M, de Imperial JM, Vidal-Sanz M. Anatomical and functional damage in experimental glaucoma. Curr Opin Pharmacol. 2013;13:5-11.
3. Vidal-Sanz M, Salinas-Navarro M, Nadal-Nicolas FM, et al. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Prog Retin Eye Res. 2012;31:1-27.
4. Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, DiPolo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res. 2012;31:152-181.
5. Parrilla-Reverter G, Agudo M, Sobrado-Calvo P, Salinas-Navarro M, Villegas-Perez MP, Vidal-Sanz M. Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res. 2009;89:32-41.
6. Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerveinjured retinas. Invest Ophthalmol Vis Sci. 2009;50:3860-3868.
7. Nadal-Nicolás FM, Jiménez-López M, Salinas-Navarro M, et al. Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLoS One. 2012;7:e49830.
8. Agudo M, Perez-Marin MC, Lonngren U, et al. Time course profiling of the retinal transcriptome after optic nerve transection and optic nerve crush. Mol Vis. 2008;14:1050-1063.
9. Agudo M, Perez-Marin MC, Sobrado-Calvo P, et al. Immediate upregulation of proteins belonging to different branches of the apoptotic cascade in the retina after optic nerve transection and optic nerve crush. Invest Ophthalmol Vis Sci. 2009;50: 424-431.
10. Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, Di PA. TrkB gene transfer protects retinal ganglion cells from axotomyinduced death in vivo. J Neurosci. 2002;22:3977-3986.
11. Leaver SG, Cui Q, Plant GW, et al. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells. Gene Ther. 2006;13:1328-1341.
12. Lebrun-Julien F, DiPolo A. Molecular and cell-based approaches for neuroprotection in glaucoma. Optom Vis Sci. 2008;85: 417-424.
13. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A. 1994;91:1632-1636.
14. Peinado-Ramon P, Salvador M, Villegas-Perez MP, Vidal-Sanz M. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:489-500.
15. Sanchez-Migallon MC, Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Vidal-Sanz M, Agudo-Barriuso M. Brain derived neurotrophic factor maintains Brn3a expression in axotomized rat retinal ganglion cells. Exp Eye Res. 2011;92: 260-267.
16. Saragovi HU, Hamel E, Di PA. A neurotrophic rationale for the therapy of neurodegenerative disorders. Curr Alzheimer Res. 2009;6:419-423.
17. Weibel D, Kreutzberg GW, Schwab ME. Brain-derived neurotrophic factor (BDNF) prevents lesion-induced axonal die-back in young rat optic nerve. Brain Res. 1995;679:249-254.
18. Nicholson JK, Holmes E, Elliott P. The metabolome-wide association study: a new look at human disease risk factors. J Proteome Res. 2008;7:3637-3638.
19. Monteiro MS, Carvalho M, Bastos MD, de Pinho PG. Metabolomics analysis for biomarker discovery: advances and challenges. Curr Med Chem. 2013;20:257-271.
20. Weiner J III, Parida SK, Maertzdorf J, et al. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS One. 2012;7:e40221.
21. Suh JH, Kim RY, Lee DS. A new metabolomic assay to examine inflammation and redox pathways following LPS challenge. J Inflamm (Lond). 2012;9:37.
22. Ganti S, Taylor SL, Abu AO, et al. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res. 2012;72:3471-3479.
23. Denkert C, Bucher E, Hilvo M, et al. Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery. Genome Med. 2012;4:37.
24. O'Connell TM. Recent advances in metabolomics in oncology. Bioanalysis. 2012;4:431-451.
25. Kim OY, Lee JH, Sweeney G. Metabolomic profiling as a useful tool for diagnosis and treatment of chronic disease: focus on obesity, diabetes and cardiovascular diseases. Expert Rev Cardiovasc Ther. 2013;11:61-68.
26. Langley SR, Dwyer J, Drozdov I, Yin X, Mayr M. Proteomics: from single molecules to biological pathways. Cardiovasc Res. 2013;97:612-622.
27. Turer AT. Using metabolomics to assess myocardial metabolism and energetics in heart failure. J Mol Cell Cardiol. 2013; 55:12-18.
28. Senn T, Hazen SL, Tang WH. Translating metabolomics to cardiovascular biomarkers. Prog Cardiovasc Dis. 2012;55:70-76.
29. Webhofer C, Gormanns P, Reckow S, et al. Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates. J Psychiatr Res. 2013;47:289-298.
30. Han X, Rozen S, Boyle SH, et al. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One. 2011;6: e21643.
31. Sato Y, Suzuki I, Nakamura T, Bernier F, Aoshima K, Oda Y. Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. J Lipid Res. 2012;53: 567-576.
32. Trushina E, Nemutlu E, Zhang S, et al. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One. 2012;7:e32737.
33. Bazenet C, Lovestone S. Plasma biomarkers for Alzheimer's disease: much needed but tough to find. Biomark Med. 2012; 6:441-454.
34. Hassan-Smith G, Wallace GR, Douglas MR, Sinclair AJ. The role of metabolomics in neurological disease. J Neuroimmunol. 2012;248:48-52.
35. Ma Y, Zhang P, Wang F, Liu W, Yang J, Qin H. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer. Ann Surg. 2012;255:720-730.
36. Blanchet L, Smolinska A, Attali A, et al. Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics. 2011;12:254.
37. Cavill R, Kamburov A, Ellis JK, et al. Consensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cells. PLoS Comput Biol. 2011;7:e1001113.
38. Eckel-Mahan KL, Patel VR, Mohney RP, Vignola KS, Baldi P, Sassone-Corsi P. Coordination of the transcriptome and metabolome by the circadian clock. Proc Natl Acad Sci U S A. 2012;109:5541-5546.
39. Fabisiak JP, Medvedovic M, Alexander DC, et al. Integrative metabolome and transcriptome profiling reveals discordant energetic stress between mouse strains with differential sensitivity to acrolein-induced acute lung injury. Mol Nutr Food Res. 2011;55:1423-1434.
40. Perco P, Muhlberger I, Mayer G, Oberbauer R, Lukas A, Mayer B. Linking transcriptomic and proteomic data on the level of protein interaction networks. Electrophoresis. 2010;31:1780-1789.
41. Xie Z, Li H, Wang K, et al. Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by highfat diet in rat. Metabolism. 2010;59:554-560.
42. Zhang Y, Filiou MD, Reckow S, et al. Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways. Mol Cell Proteomics. 2011;10: M111.
43. Zhang Y, Zhang X, Wu B, Cheng S. Evaluating the transcriptomic and metabolic profile of mice exposed to source drinking water. Environ Sci Technol. 2012;46:78-83.
44. Parrilla-Reverter G, Agudo M, Nadal-Nicolas F, et al. Timecourse of the retinal nerve fibre layer degeneration after complete intra-orbital optic nerve transection or crush: a comparative study. Vision Res. 2009;49:2808-2825.
45. Quintas G, Garcia-Cañaveras JC, Castell JV, Ferrer A, Lahoz A. Chemometric approaches to improve PLSDA model outcome for predicting human non-alcoholic fatty liver disease using UPLC-MS as a metabolic profiling tool. Metabolomics. 2012;8: 86-98.
46. Lindgren F, Hansen B, Karcher W, Sjöström M, Eriksson M. Model validation by permutation tests: Applications to variable selection. J Chemom. 1996;10:521-532.
47. Chong IG, Jun CH. Performance of some variable selection methods when multicollinearity is present. Chemom Intell Lab Syst. 2005;78:103-112.
48. Mathias S, Pena LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J. 1998;335:465-480.
49. Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog Brain Res. 2008;173:409-421.
50. Agudo M, Nadal-Nicolas FM, Perez-Marin MC, et al. TNFR1 death-signalling pathway is regulated in the retina after optic nerve transection and optic nerve crush. Invest Ophthalmol Vis Sci. 2009;50:3467.
51. Weishaupt JH, Diem R, Kermer P, Krajewski S, Reed JC, Bahr M. Contribution of caspase-8 to apoptosis of axotomized rat retinal ganglion cells in vivo. Neurobiol Dis. 2003;13:124-135.
52. Stratford S, Hoehn KL, Liu F, Summers SA. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem. 2004;279:36608-36615.
53. Hansen HH, Ikonomidou C, Bittigau P, Hansen SH, Hansen HS. Accumulation of the anandamide precursor and other Nacylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death. J Neurochem. 2001; 76:39-46.
54. Garg P, Duncan RS, Kaja S, Koulen P. Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke. Neuroscience. 2010;166:252-262.
55. Nucci C, Bari M, Spano A, et al. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection. Prog Brain Res. 2008;173:451-464.
56. Harada J, Sugimoto M. Polyamines prevent apoptotic cell death in cultured cerebellar granule neurons. Brain Res. 1997;753: 251-259.
57. Bakalash S, Pham M, Koronyo Y, et al. Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease. Invest Ophthalmol Vis Sci. 2011;52:9033-9046.
58. Kamphuis W, Dijk F, van Soest S, Bergen AA. Global gene expression profiling of ischemic preconditioning in the rat retina. Mol Vis. 2007;13:1020-1030.
59. Brocker C, Thompson DC, Vasiliou V. The role of hyperosmotic stress in inflammation and disease. Biomol Concepts. 2012;3:345-364.
60. Hernandez C, Simo R. Neuroprotection in diabetic retinopathy. Curr Diab Rep. 2012;12:329-337.
61. Chidlow G, Wood JP, Casson RJ. Pharmacological neuroprotection for glaucoma. Drugs. 2007;67:725-759.
62. Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013; 1830:3143-3153.